Molecular Medicine
The Molecular Medicine Residency track within the Categorical Medicine Residency is designed for individuals who are interested in pursuing a career that emphasizes bench research in combination with the practice of medicine. The overarching goal of the program is to train the next generation of transformative laboratory-based physician-scientists.
The Molecular Medicine Residency provides specialized, individualized attention to each participant’s development as a bench scientist while maintaining the same broad and intensive exposure to clinical medicine that is enjoyed by all UCSF categorical internal medicine residents. Admission to the program is accompanied by a guaranteed subspecialty fellowship position within the Department of Medicine, contingent upon satisfactory completion of residency training. Successful applicants demonstrate potential for excellence in both clinical care and laboratory research, and will have completed a successful MD/PhD program or an in-depth research experience of at least one year.
Curriculum
Molecular Medicine Residents receive personal mentoring in selecting their area of research and choosing laboratories that may be of interest to them for training. They also meet regularly as a group for career guidance seminars and for scientific discussions in a relaxed, informal setting, and attend an annual dinner designed to facilitate interaction among members of the Department’s College of Bench Scientists. Dedicated time for scholarly activity is provided during the R2 year (and R3 year, if applicable). During the R2 year, Molecular Medicine Residents travel to the annual 3-day research retreat of the Biomedical Sciences Program in Lake Tahoe, California, where they can learn more about the rich scientific opportunities at UCSF and an have opportunity to fully immerse themselves in basic/translational science. Molecular Medicine Residents also participate in conferences of the UCSF Molecular Medicine Consult Service, which is designed to promote scientific inquiry among all residents. This service endeavors to apply state-of-the-art tools toward a better understanding of the molecular pathophysiology of disease. Historically, the majority of Molecular Medicine Residents have, pending approval from the Categorical Residency Program Director, opted to short-track into the ABIM Research Pathway.
Current Molecular Medicine Residents
*Click here to learn more about current and former Molecular Medicine residents at UCSF.
Year |
Name and Degree(s) |
Degree Granting Institution |
R3 2018 |
John Huizar, MD |
University of California, San Francisco |
R3 2018 |
Worawan Limpitikul, MD, PhD |
Johns Hopkins University |
R3 2018 |
Natasha Spottiswoode, MD, PhD |
Columbia University |
R2 2019 |
Ryan Chang, MD, PhD |
University of California, San Francisco |
R2 2019 |
Mai Dao, MD |
Harvard University |
R2 2019 |
Charlotte Hurabielle-Claverie, MD, PhD |
Faculte de Medecine Paris Descartes |
R2 2019 |
Anjali Jacob, MD, PhD |
Boston University |
R2 2019 |
Matthew Jones, MD, PhD |
University of Chicago |
R2 2019 |
Vipul Kumar, MD, PhD |
Harvard University |
R2 2019 |
Quinlan Siervers, MD, PhD |
Harvard University |
R2 2019 |
Jeremiah Wala, MD, PhD |
Harvard University |
R2 2019 |
Robert Weber, MD, PhD |
University of California, San Francisco |
R2 2019 |
Andrew Lechner, MD, PhD |
University of California, San Francisco |
R1 2020 | Erin dela Cruz, MD, PhD | University of Washington |
R1 2020 | Vivek Durai, MD, PhD | Washington University, St Louis |
R1 2020 | Benjamin Hoffman, MD, PhD | Columbia University |
R1 2020 | Alissa Kleinhenz, MD | University of Michigan |
R1 2020 | Nathan Krah, MD, PhD | University of Utah |
R1 2020 | Guy Ledergor, MD, PhD | Hadassah Medical School |
R1 2020 | Donna Leet, MD | Harvard University |
R1 2020 | Sophia Levan, MD, PhD | University of California, San Francisco |
R1 2020 | Alejandro Lopez, MD, PhD | Cornell University |
R1 2020 | Shirley Mo, MD | Harvard University |
R1 2020 | Rangarajan Nadadur, MD, PhD | University of Chicago |
R1 2020 | Coyin Oh, MD | Harvard University |
R1 2020 | Kimberly Rickman, MD PhD | Cornell University |
Recent Participants
Degree Granting Institution | Name | Subspecialty |
---|---|---|
2014 Harvard |
Vincent Auyeung, MD, PhD |
Pulmonary Disease and Critical Care Medicine, UCSF |
2014 UCSF |
Alan Baik, MD |
Cardiology, UCSF |
2014 UCSF |
Jonathan Chou, MD, PhD |
Hematology and Oncology, UCSF |
2014 University of Washington |
Joseph Hiatt, MD, PhD |
Hematology and Oncology, University of Washington |
2015 University of Pennsylvania |
Chukwuka Didigu, MD, PhD |
Hematology and Oncology, UCSF |
2015 Harvard |
Laura Huppert, MD, |
Hematology and Oncology, UCSF |
2015 Washington University |
Hailyn Nielsen, MD, PhD |
Rheumatology, UCSF |
2015 University of Chicago |
Vaibhav Upadhyay, MD, PhD |
Pulmonary Disease and Critical Care Medicine, UCSF |
2016 Yale |
Nancy Allen, MD, PhD |
Pulmonary Disease and Critical Care Medicine, UCSF |
2016 Columbia |
Stewart Cao, MD, PhD |
Gastroenterology, Washington University, St. Louis |
2016 University of Michigan |
Cailin Collins, MD, PhD |
Hematology and Oncology, Stanford University |
2016 Baylor |
Andrew Folick, MD, PhD |
Endocrinology, UCSF |
2016 Johns Hopkins |
Bridget Keenan, MD, PhD |
Hematology and Oncology, UCSF |
2016 Icahn School of Medicine at Mount Sinai |
Arielle Klepper, MD, PhD |
Geriatrics, UCSF |
2016 Pennsylvania State University College of Medicine |
Michelle Matzko, MD, PhD |
Infectious Diseases, MGH/BWH |
2016 UCSF |
Alex Mohapatra, MD, PhD |
Pulmonary Disease and Critical Care Medicine, UCSF |
2016 Baylor |
Kapil Saxena, MD |
Hematology and Oncology, MDACC |
2017 New York University |
Adam Blaisdell, MD, PhD |
Gastroenterology, UCSF |
2017 Univeristy of Pittsburgh |
John Demko, MD |
Nephrology, UCSF |
2017 University of California, Irvine | Kelly Fitzgerald, MD | Hematology and Oncology, Memorial Sloan-Kettering Cancer Center |
2017 Yale | Brendan Huang, MD, PhD | Pulmonary Disease and Critical Care Medicine, UCLA |
2017 University of North Carolina | Meghan Jobson, MD, PhD | Palliative Care, UCSF |
2017 Cornell | Corynn Kasap, MD, PhD | Hematology and Oncology, UCSF |
2017 Cornell | Maxime Kinet, MD, PhD | Rheumatology, UCSF |
2017 Icahn School of Medicine at Mt Sinai | Noa Simchoni, MD, PhD | Hospital Medicine, UCSF |
2017 UCSF | Noah Younger, MD, PhD | Hematology and Oncology, UCSF |
2018 UCSF | Christina Homer, MD, PhD | Infectious Diseases, UCSF |
2018 University of Pennsylvania | Sarah Hsu, MD, PhD | Hematology and Oncology, UCSF |
2018 Duke University | Jerry Lee, MD | Hematology and Oncology, UCSF |
2018 UCSF | T. Richard Parenteau, MD, PhD | Geriatrics, UCSF |
2018 University of Iowa | Joshua Schoenfeld, MD, PhD | Hematology and Oncology, Memorial Sloan-Kettering Cancer Center |
2018 Harvard University | Travis Zack, MD, PhD | Hematology and Oncology, UCSF |
Application Logistics
Upon receipt of the electronic Residency Application from ERAS, the Residency Admissions Committee selects applicants for interview at UCSF. Applicants invited for an interview are then asked if they wish to be considered for the Molecular Medicine Residency. A separate selection committee reviews applicants and issues invitations to remain an extra day after the Categorical Residency application day to interview specifically for the Molecular Medicine Residency.
As stated above, acceptance into the Molecular Medicine Residency includes a commitment of a fellowship position in a specialty of choice. A Molecular Medicine Residency participant, however, may also choose not to specify a particular specialty and, instead, wait to apply after exploring different opportunities during residency.
The UCSF Molecular Medicine Residency Program is fully committed to enhancing diversity at UCSF.
Applications from women and under-represented ethnic/cultural groups are strongly encouraged.
Neil P. Shah, MD PhD
Director, UCSF Molecular Medicine Residency Program
Contact Us
Additional questions may be addressed to Vivian Robinson.
Vivian Robinson
415-476-3373
[email protected]
Thank you for your interest in the UCSF Molecular Medicine Residency Program.